ask="2.5000"
ask_size="500"
average_daily_volume="1072230"
bid="2.3500"
bid_size="500"
book_value="-0.0330"
change="-0.1399"
change_from_200_day_moving_average="0.6580"
change_from_50_day_moving_average="0.2323"
change_from_52_week_high="-1.5699"
change_From_52_week_low="1.3201"
change_in_percent="-5.4436%"
close="2.4301"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.5100"
ebitda="-13.34M"
eps_estimate_current_year="-1.2300"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="0.9500"
ex_dividend_date="N/A"
float_shares="4867000"
high="2.5900"
high_52_weeks="4.0000"
last_trade_date="3/16/2017"
last_trade_price="2.4301"
last_trade_size="1440"
last_trade_time="3:59pm"
low="2.3500"
low_52_weeks="1.1100"
market_capitalization="24.87M"
moving_average_200_day="1.7721"
moving_average_50_day="2.1978"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.0000"
open="2.5900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+37.1311%"
percent_change_from_50_day_moving_average="+10.5697%"
percent_change_from_52_week_high="-39.2475%"
percent_change_from_52_week_low="+118.9279%"
previous_close="2.5700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.5580"
price_per_book="N/A"
price_per_sales="39.2993"
revenue="669259.00"
shares_outstanding="10234000"
short_ratio="0.2100"
stock_exchange="NCM"
symbol="EYEG"
volume="414300"
weeks_range_52="1.1100 - 4.0000"
